Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HLA Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04827979
What this trial is testing

Daratumumab and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 19
Not applicableStudy completedNCT00006298
What this trial is testing

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 125
Testing effectiveness (Phase 2)Study completedNCT00446459
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 45
Not applicableNot Yet RecruitingNCT06956469
What this trial is testing

BmemHLA : Origins of the Heterogeneity of the Anti-HLA Memory B Cells in Kidney Transplantation

Who this might be right for
Kidney TransplantationImmunology
University Hospital, Bordeaux 75
Not applicableUnknownNCT03714113
What this trial is testing

Donor-specific Anti-HLA Antibodies Monitoring in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Medical University of Warsaw 100
Testing effectiveness (Phase 2)Study completedNCT00005940
What this trial is testing

Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+4 more
Fred Hutchinson Cancer Center 18
Not applicableStudy completedNCT03238443
What this trial is testing

Interest of the Donor-specific Antibodies After Liver Transplantation

Who this might be right for
Liver Transplant
University Hospital, Lille 120
Not applicableEnded earlyNCT01334281
What this trial is testing

An In-vitro Standardization of B Cell Elispot Assays

Who this might be right for
Transplant SensitizationPanel Reactive AntibodySensitization to HLA Antigens
Northwestern University 19
Testing effectiveness (Phase 2)Study completedNCT00002554
What this trial is testing

Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05017545
What this trial is testing

Carfilzomib and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 21
Not applicableStudy completedNCT06395220
What this trial is testing

Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Haematological Malignancy
Peking University People's Hospital 314
Testing effectiveness (Phase 2)Study completedNCT00003870
What this trial is testing

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT01349595
What this trial is testing

Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation

Who this might be right for
Disorder of Transplanted Kidney
Mark Stegall 4
Not applicableStudy completedNCT07474857
What this trial is testing

Anti-HLA Antibodies After Bone Regeneration Surgery

Who this might be right for
Alveolar Bone LossMaxillary Sinus Bone Loss
Medical Innovation Center Wroclaw 20
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01178216
What this trial is testing

Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

Who this might be right for
End Stage Renal Disease
Stanley Jordan, MD 41
Post-approval studies (Phase 4)Study completedNCT04225988
What this trial is testing

Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Cedars-Sinai Medical Center 20
Early research (Phase 1)WithdrawnNCT04579523
What this trial is testing

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Who this might be right for
Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Fred Hutchinson Cancer Center
Not applicableEnded earlyNCT02115503
What this trial is testing

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients

Who this might be right for
Renal Transplant Recipients With Anti-HLA Antibodies
Databean 52
Large-scale testing (Phase 3)Study completedNCT00094653
What this trial is testing

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

Who this might be right for
MelanomaMetastases
Bristol-Myers Squibb 1,783
Next Page